Altamira TherapeuticsCYTOF
13F holders, Q3 2024 (September 30)5holders +1
3new positions
2sold out
1famous investor
$0.61avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Altamira Therapeutics Ltd. (CYTOF) in their 13F filings, up 1 from Q2 2024. 3 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($62K), Citadel Advisors ($9K) and Group One Trading LLC ($9). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Altamira Therapeutics Ltd.
- CUSIP
- G0360L134
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $71K |
| Exits | 2 | $3K |
All 13F filers, Q2 2024 → Q3 2024: 116,247 shares bought and 2,644 shares sold, net +113,603 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Armistice Capital, LLC | 0.00% | New | 101,444 | $62K |
| Citadel Advisors | 0.00% | New | 14,802 | $9K |
| Group One Trading LLC | 0.00% | No change | 14 | $9 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
| LRI Investments, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CYTOF's weight in each manager's 13F, not the share of Altamira Therapeutics Ltd. the manager owns.